As interest in using psychedelics to treat a range of mental health disorders grows, researchers consider the impact and therapeutic benefits of using psychedelics to help alleviate symptoms of depression.
While the effects of hallucinogens to treat mental illnesses are being researched, little is known about the neurobiology of those who dabble in psychedelics for recreational purposes. A new study reports "psychonauts" have distinct behaviors, including taking a scientific approach to documenting their experience with hallucinogens, compared to more recreational users.
Researchers have uncovered the structure of psychedelic compounds when they actively bind to the 5-HT2A serotonin receptor on the surface of brain cells. The discovery could lead to the exploration of more precise compounds that offer the therapeutic effects of psychedelics for mental health disorders, but without the hallucinations.
Researchers explore why using hallucinogens to treat an array of mental health disorders is becoming more popular.
Researchers explore the potential benefits of using hallucinogens for the treatment of PTSD, anxiety, depression and other mental health disorders.
A new study will investigate whether psilocybin can help curb cocaine addiction. Researchers are currently seeking people with a history of cocaine abuse to participate in the study.
Researchers report lower levels of activity in the amygdala, an area of the brain associated with fear, in people under the influence of LSD.
While many people reported a 'bad trip' when taking psilocybin containing mushrooms, most report experiencing meaningful and worthwhile experiences while under the influence.
